Investigating Intranasal Oxytocin as a Treatment for Women's Chronic Pelvic Pain: A Feasibility Study

Simple item page
dc.contributor.advisorCampbell, Tavis S.
dc.contributor.authorFlynn, Michelle Jacqueline
dc.contributor.committeememberNoel, Melanie
dc.contributor.committeememberBergeron, Sophie
dc.contributor.committeememberMcGrath, Daniel S.
dc.date2018-11
dc.date.accessioned2018-09-26T15:25:02Z
dc.date.available2018-09-26T15:25:02Z
dc.date.issued2018-09-14
dc.description.abstractChronic pelvic pain (CPP) affects approximately 5.7-26.6% of women in the general population and has limited treatment options. Administration of oxytocin (OT) has been associated with reductions in pain in other chronic pain conditions. The current feasibility study was the first to investigate the OT-pain association in women with CPP. The aims were: 1) determine if a clinically significant change in pain intensity (1-centimeter improvement on a 10-centimeter visual analogue scale) could be detected following intranasal OT administration; 2) identify challenges in treatment and study protocol implementation. Women with CPP (N=18) were recruited from chronic pain and gynecology clinics for this randomized, double-blind, within-subject crossover trial (Registration#NCT02888574). Exclusion criteria included pregnancy, primary diagnosis of endometriosis, dysmenorrhea, interstitial cystitis, functional bowel disorder, fibromyalgia, or neuropathic pain. Currently, 11 women have completed the trial (2-weeks OT, 2-weeks washout, 2-weeks placebo, with random order of OT and placebo). Women recorded symptoms of pain at baseline and in daily diaries. One participant dropped out due to headaches following placebo administration, one did not complete daily diaries, and two were randomized despite having pain only during intercourse, leaving seven women in the analyses. Clinically significant change was reported for average and current pain following OT and placebo administration. Self-reported treatment adherence was near perfect. Participants viewed the treatment as credible, anticipating improved pain. Daily diary adherence was good. Challenges with protocol implementation highlight the need for more systematic eligibility assessments and recruitment strategies, and moving daily diaries to an online platform. Overall, a clinically significant change was detected on pain and the treatment protocol was feasible, though some adjustments to the study protocol are warranted before a subsequent trial is completed.en_US
dc.identifier.citationFlynn, M. J. (2018). Investigating intranasal oxytocin as a treatment for women's chronic pelvic pain: A feasibility study (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca. doi:10.11575/PRISM/32984en_US
dc.identifier.doihttp://dx.doi.org/10.11575/PRISM/32984
dc.identifier.urihttp://hdl.handle.net/1880/108043
dc.language.isoeng
dc.publisher.facultyArts
dc.publisher.facultyGraduate Studies
dc.publisher.institutionUniversity of Calgaryen
dc.publisher.placeCalgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.
dc.subjectChronic pain
dc.subjectchronic pelvic pain
dc.subjectoxytocin
dc.subjectintranasal oxytocin
dc.subjectfeasibility study
dc.subjectrandomized clinical trial
dc.subject.classificationMental Healthen_US
dc.subject.classificationObstetrics and Gynecologyen_US
dc.subject.classificationPsychologyen_US
dc.titleInvestigating Intranasal Oxytocin as a Treatment for Women's Chronic Pelvic Pain: A Feasibility Study
dc.typemaster thesis
thesis.degree.disciplineClinical Psychology
thesis.degree.grantorUniversity of Calgary
thesis.degree.nameMaster of Science (MSc)
ucalgary.item.requestcopytrue
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ucalgary_2018_flynn_michelle.pdf
Size:
746.91 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Theses and Dissertations